Does PTSD Go Away? Understanding Long-Term Outcomes

Living with PTSD means carrying a question that most people around you cannot fully see: is this permanent? Is this what life looks like now?

That question deserves a real clinical answer, not platitudes. The research on PTSD long-term outcomes is more nuanced than most content acknowledges, and understanding it changes both what people expect from recovery and what they do to pursue it.

What This Page Covers

• What natural recovery from PTSD looks like and its limits
• What the evidence shows about recovery with treatment
• The predictors that determine whether PTSD becomes chronic
• What the non-linear recovery pattern actually means
• Co-occurring depression and anxiety in PTSD and why they matter
• What long-term care looks like beyond the acute phase

What Natural Recovery Looks Like

Some people recover from PTSD without formal treatment. Understanding when this happens, and when it does not, helps set realistic expectations.

Natural recovery from PTSD is most likely in the early aftermath of trauma. The majority of recovery in PTSD without treatment occurs within the first three months following trauma, with little change in PTSD prevalence observed beyond this point.

A systematic review and meta-analysis of 42 studies with 81,642 participants looked specifically at spontaneous long-term remission from PTSD without specific treatment.

Across all studies, an average of 44 percent of individuals with PTSD at baseline were non-cases at follow-up, with remission varying between 8 and 89 percent. In studies where baseline assessment occurred within the first five months following trauma, the remission rate was 51.7 percent, compared to 36.9 percent when baseline was later than five months after trauma.

Two findings stand out from this data:

First, natural recovery is not rare in the early period. About half of people assessed within five months of trauma eventually remit without treatment.

Second, if symptoms persist beyond several months, natural recovery becomes significantly less likely. The 36.9 percent remission rate for later-assessed samples represents people who have already survived the initial natural recovery window without improving.

The Median Time to Natural Remission Is 14 Years

Perhaps the most important finding about untreated PTSD comes from a large population study.

The projected lifetime remission rate for PTSD in the general population was 92 percent, but the median time to remission was 14 years. Those who experienced childhood trauma, interpersonal violence, severe symptoms, or a secondary anxiety or affective disorder were less likely to remit and reported longer median times to remission.

Most people with PTSD do eventually reach remission, but 14 years is an enormous amount of unnecessary suffering, functional impairment, relationship damage, and risk of comorbid conditions.

What Recovery With Treatment Looks Like

Evidence-based treatment dramatically changes these numbers.

After cognitive processing therapy (CPT) or prolonged exposure (PE), between 53 and 63 percent of adults achieve clinical remission. These outcomes come from within months, not years.

A recent study found clinically significant reductions in PTSD symptoms in more than 60 percent of patients and long-term remission of PTSD diagnosis in more than 50 percent after three weeks of intensive outpatient Prolonged Exposure therapy in combat veterans.

The therapies with the strongest evidence base are:

Cognitive Processing Therapy (CPT): 12 sessions focused on the distorted beliefs that maintain PTSD, addressing stuck points, self-blame, and the conviction that the world is completely unsafe or that the person is permanently damaged.

Prolonged Exposure (PE): Systematic, graduated engagement with trauma-related memories and avoided situations. By confronting rather than avoiding trauma in a therapeutic context, the fear response diminishes through inhibitory learning.

EMDR: Eye movement desensitization and reprocessing involves bilateral stimulation while processing trauma memories. The mechanism is not fully understood, but the clinical evidence is consistent and strong.

The APA’s 2025 Clinical Practice Guideline strongly recommends these three therapies as first-line treatment for PTSD. Network meta-analyses show CPT, EMDR, and cognitive therapy produce the largest effect sizes for PTSD symptom reduction, sustained at long-term follow-up.

Who Is Most Likely to Develop Chronic PTSD

Not everyone with PTSD follows the same trajectory. Several factors consistently predict a more chronic course:

Type of trauma. Interpersonal trauma, particularly childhood abuse, sexual violence, and repeated trauma, carries significantly higher risk of chronic PTSD than single-incident trauma from accidents or natural disasters. Natural disaster PTSD showed the highest mean remission rate (60 percent), while PTSD from physical disease showed the lowest (31.4 percent).

Timing of symptoms. The longer symptoms persist without treatment, the less likely natural recovery becomes.

Co-occurring conditions. PTSD with a secondary anxiety or affective disorder significantly reduces remission rates compared to PTSD without comorbidity. Depression and anxiety are both consequences and maintaining factors of PTSD.

Avoidance. The more situations, memories, and emotions are avoided, the more the PTSD is reinforced. Avoidance provides short-term relief and long-term perpetuation.

Social support. Isolation compounds PTSD. Research confirms that social support is protective for recovery.

The Non-Linear Recovery Pattern

Recovery from PTSD is not a steady progression from symptomatic to recovered. Understanding this in advance reduces the risk of misinterpreting difficult weeks as evidence that treatment is failing.

The typical pattern in treatment is meaningful improvement over the first three to four months, a period of greater stability, a harder period triggered by a stressor or anniversary, then movement back toward improvement. The hard periods become less severe over time. Recovery from them becomes faster. Things that once triggered full-intensity flashbacks become manageable.

About 80 percent of people with PTSD have at least one comorbid condition, most commonly depression, anxiety, or substance use disorder. These comorbidities often develop over time and require separate clinical attention.

Symptom re-emergence after a period of stability is not relapse as a permanent state. It is a clinical signal that the current treatment plan may need updating, that a new stressor has entered the picture, or that a comorbid condition needs attention.

Co-Occurring Depression and Anxiety in PTSD

PTSD rarely exists without company.

The depression and anxiety that co-occur with PTSD are not just secondary symptoms that will resolve when the PTSD is treated. They often develop through separate pathways and require their own attention.

SSRIs, specifically sertraline and paroxetine, are FDA-approved for PTSD and also treat depression and anxiety disorders directly. They are most useful as part of a comprehensive plan rather than as the sole treatment, and research shows that combined medication and trauma-focused therapy produces better outcomes than either alone.

For people whose depression or anxiety is severe enough to interfere with engagement in trauma-focused therapy, treating co-occurring conditions first or concurrently often improves the ability to do the harder trauma work. A care team that monitors both dimensions produces better results than addressing only one.

What Long-Term Care Looks Like After the Acute Phase

One of the patterns in PTSD research that gets too little attention is what happens after the acute treatment phase. Full remission is achievable. But for a significant proportion of people, PTSD involves an ongoing clinical relationship that adjusts over time.

Even after PTSD symptoms have remitted, some people experience lingering effects on functional capacity, including quality of life in psychological, physical, social, and environmental domains, compared to those who never developed PTSD.

This is not a reason for pessimism. It is a reason to maintain access to clinical support rather than treating PTSD as a closed chapter when symptoms decrease.

About SiggyMD

SiggyMD’s current clinical scope is depression and anxiety, including the mood and anxiety disorders that frequently co-occur with PTSD. For PTSD-specific trauma-focused therapy, a CPT-, PE-, or EMDR-trained clinician is the appropriate resource.

For the depression and anxiety that accompany PTSD, SiggyMD provides continuous clinician-supervised medication management with daily check-ins. When a prescriber can see how mood and anxiety are trending between appointments rather than reconstructing it at a quarterly visit, adjustments happen before a developing problem deepens.

“A lot of what I see in patients managing PTSD is the depression and anxiety that developed alongside it and have never been adequately treated,” says Wendy Delgado, P.A., of the SiggyMD clinical team. “Those conditions are treatable. And treating them changes how much cognitive and emotional bandwidth is available for the other recovery work.”

The anonymous intake is free and requires no name, no email, and no account to begin.

For more on related topics, see our guides on what PTSD is, complex PTSD vs. PTSD, and how to manage PTSD between appointments.

Start your anonymous intake at SiggyMD to connect with a licensed prescriber who can address the depression and anxiety components of your picture.

What Members Are Saying

RS

R.S., 41

PTSD, Depression

“I waited four years thinking it would get better on its own. It didn’t. When I finally started treatment, the CPT work was hard but the progress was real. I wish someone had told me earlier that waiting was not neutral. Every year without treatment was making the depression worse and the avoidance patterns more entrenched.”

MT

M.T., 33

Combat PTSD, Anxiety

“What no one explained to me was that the non-linear part is normal. I had a really good month, then a terrible week, and thought I had lost everything I’d gained. My prescriber said that was the expected pattern. Understanding that kept me in treatment. The overall trajectory continued upward even though it didn’t feel like it in the hard weeks.”

Member stories reflect real experiences. Names and identifying details have been changed to protect privacy. Results vary.

The Bottom Line

PTSD does not reliably go away on its own. Natural recovery does occur, particularly in the first months after trauma, but for the majority of people with persistent PTSD, waiting is not a treatment strategy. The median time to natural remission without treatment is 14 years.

With evidence-based treatment, recovery timelines shorten dramatically, and the majority of people who receive adequate treatment achieve significant symptom reduction or clinical remission.

Recovery is not linear. Hard periods are part of the pattern. Comorbid depression and anxiety need their own attention. And maintaining a clinical relationship beyond the acute treatment phase improves long-term outcomes.

If you are in crisis or having thoughts of self-harm, call or text 988. If you are in immediate danger, call 911.

Sources

1. Morina N, Wicherts JM, Lobbrecht J, Priebe S. Remission from post-traumatic stress disorder in adults: A systematic review and meta-analysis of long term outcome studies. Clinical Psychology Review. 2014;34(3):249-255.

2. Slade T, et al. Remission from post-traumatic stress disorder in the general population. Psychological Medicine. 2012;42(8):1697-1706.

3. American Psychological Association. Clinical Practice Guideline for the Treatment of PTSD in Adults. APA, 2025.

4. UT Health San Antonio. Treatment for combat-related PTSD advances with method shown to be fast, effective. 2024.

5. Schrader C, Ross A. A review of PTSD and current treatment strategies. Missouri Medicine. 2021;118(5):419-423.

6. Bryant RA, et al. The lingering impact of resolved PTSD on subsequent functioning. Focus. 2023.

7. FHE Health. Will PTSD Go Away? Accessed June 2026.

8. National Institute of Mental Health. Post-Traumatic Stress Disorder. Revised 2023.

9. Charlie Health. Treatment-Resistant PTSD. Accessed June 2026.